에 대한 최신 뉴스 Synopsys (NASDAQ:SNPS) 주식

Synopsys

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Equities

Large Cap

Broad U.S. Equity ETFs

Federal Reserve

Markets

Movers

Tech

ETFs

AKAM

EXPE

MNST

PANW

SNPS

TTWO

S&amp;P 500 지수는 금요일 0.4% 상승한 5,344포인트로 마감하여 2일 연속 상승세를 기록했으며, 주 초반의 급락과 높은 변동성으로 생긴 손실을 완전히 만회했다.

S&amp;P 500은 주간 손실을 만회, 나스닥 100은 강세장이 모멘텀을 되찾으며 4주 하락세를 마감

News

Global

ATEYY

MRVL

NVDA

SMCI

다가오는 엔비디아(NASDAQ:NVDA)의 분기 실적 결과는 이 회사의 관심사일 뿐만 아니라 엔비디아가 더 나은 성과를 낼 때 상승하는 경향이 있는 다른 인공지능(AI) 관련 주식 6종목에도 관심이 있다. 발생한 일 (What Happened): CNBC에 따르면 분석 결과 엔비디아가 예상을 뛰어넘을 때 일반적으로 긍정적인 반응을 보이는 6개의 AI 관련 주식이 확인되었다.

엔비디아의 성공은 이 6종목의 인공지능 관련 주식을 신고점으로 인도할 것

Synopsys Inc

SYNOPSYS ORD

Loop Capital analyst Gary Mobley initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announces Price Target of $675.

Price Target

Initiation

Analyst Ratings

Loop Capital Initiates Coverage On Synopsys with Buy Rating, Announces Price Target of $675

WIIM

ACIW

ADBE

ADEA

ADSK

AEYE

AGYS

AISP

AIXI

ALKT

ANSS

APPF

APPN

ARBK

ASAN

BILL

BLKB

BRZE

BTCM

BTCS

BTCT

CCSI

CIFR

CRWD

CVLT

CWAN

CYBR

DATS

DJCO

DOCU

DOMO

EGAN

EVCM

FICO

FTNT

GRYP

GTLB

HTCR

HUBS

IDAI

IDCC

INTA

INTU

IREN

KVYO

LMFA

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MNDY

MSTR

NCNO

ORCL

PCOR

PLTR

SDIG

SLNH

SOUN

SPNS

SPSC

SSTI

TENB

VRNS

WDAY

XTKG

ZETA

Shares of software companies are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) has outperformed the market over the past 5 years by 17.8% on an annualized basis producing an average annual return of 31.47%. Currently, Synopsys has a market capitalization of $81.29 billion. 
Buying $100 In SNPS: If an investor had bought $100 of SNPS stock 5 years ago, it would be worth $392.41 today based on a price of $529.21 for SNPS at the time of writing.
<h3>Synopsys's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730300413_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Synopsys Stock In The Last 5 Years

Synopsys shares are trading higher in possible sympathy with Cadence Design Systems, which reported strong Q3 earnings.

The UK's antitrust watchdog has <a href="https://www.gov.uk/cma-cases/synopsys-slash-ansys-merger-inquiry" target="_blank" rel="noreferrer noopener">launched an investigation</a> into Synopsys Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) $34 billion acquisition of software developer Ansys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>).
On Friday, the Competition and Markets Authority (CMA) announced it had opened an initial phase one merger review due to potential competition concerns.
The CMA has recently intensified scrutiny in the tech sector, focusing on mergers involving AI, cloud services, and chip design, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-10-25/synopsys-34-billion-ansys-deal-gets-uk-antitrust-scrutiny?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/41008834/ansys-taiwan-semiconductor-microsoft-team-up-to-supercharge-next-gen-chip-simulations" rel="noreferrer noopener">ANSYS, Taiwan Semiconductor, Microsoft Team Up To Supercharge Next-Gen Chip Simulations</a>
Synopsys acquired Ansys to broaden its customer base and product offerings.
Under the deal, Ansys shareholders will <a href="https://www.benzinga.com/m-a/24/01/36646413/why-is-ansys-stock-trading-lower-tuesday" target="_blank" rel="noreferrer noopener">receive $197 in cash</a> and 0.345 shares of Synopsys stock for each Ansys share they own.
The CMA will determine by Dec. 20 whether the investigation will proceed to an in-depth review.
The CMA has <a target="_blank" href="https://www.benzinga.com/government/24/10/41528255/googles-2b-investment-in-anthropic-under-scrutiny-uk-opens-competition-inquiry" rel="noreferrer noopener">opened an investigation</a> into Google's $2 billion investment in AI startup Anthropic, assessing its potential impact on competition. This regulatory step follows CMA's recent approval of a similar Amazon-Anthropic partnership.
Microsoft, which invested $10 billion in OpenAI, recently gave up its observer seat on OpenAI's board amid rising global regulatory pressure on Big Tech's AI investments.
Price Actions: ANSS stock was up 1.38% at $325.80, while shares of SNPS were up 1.5% at $502.48 at the time of publication Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41522973/intel-triumphs-in-15-year-legal-battle-eu-court-rejects-record-antitrust-penalty" target="_blank" rel="noreferrer noopener">Intel Triumphs In 15-Year Legal Battle, EU Court Rejects Record Antitrust Penalty</a></li>
</ul>
Photo: Shutterstock

Government

Regulations

Media

UK Launches Antitrust Review Of Synopsys' $34 Billion Ansys Deal Over Growing Concerns

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird raised ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) price target from $900 to $975. Baird analyst Rob Oliver maintained an Outperform rating. ServiceNow shares closed at $907.68 on Wednesday. <a href="https://www.benzinga.com/quote/NOW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc raised the price target for Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) from $11 to $12. Keybanc analyst Michael Leshock maintained an Overweight rating. Rocket Lab shares closed at $10.91 on Wednesday. <a href="https://www.benzinga.com/quote/RKLB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) from $687 to $670. Piper Sandler analyst Clarke Jeffries maintained an Overweight rating. Synopsys shares closed at $493.41 on Wednesday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. raised DBV Technologies S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) price target from $5 to $7. HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating. DBV Technologies shares settled at $0.6801 on Wednesday. <a href="https://www.benzinga.com/quote/DBVT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham boosted Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) price target from $482 to $528. Needham analyst James Ricchiuti maintained a Buy rating. Teledyne Technologies shares closed at $470.09 on Wednesday. <a href="https://www.benzinga.com/quote/TDY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut NextEra Energy Partners, LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) price target from $25 to $22. JP Morgan analyst Mark Strouse upgraded the stock from Underweight to Neutral. NextEra Energy shares closed at $21.01 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See </a><a href="https://www.benzinga.com/quote/NEP/analyst-ratings">how </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">other analysts view this stock</a>.</li>
<li>BMO Capital cut the price target for CoStar Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) from $78 to $75. BMO Capital analyst Jeffrey Silber maintained a Market Perform rating. CoStar shares settled at $72.82 on Wednesday. <a href="https://www.benzinga.com/quote/CSGP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised Amphenol Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) price target from $70 to $74. B of A Securities analyst Wamsi Mohan maintained a Neutral rating. Amphenol shares closed at $68.47 on Wednesday. <a href="https://www.benzinga.com/quote/APH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised the price target for Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from $255 to $265. B of A Securities analyst John Murphy maintained a Buy rating. Tesla shares closed at $213.65 on Wednesday. <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. boosted East West Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) price target from $91 to $104. Stephens &amp; Co. analyst Andrew Terrell maintained an Overweight rating. East West Bancorp shares closed at $95.63 on Wednesday. <a href="https://www.benzinga.com/quote/EWBC/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read More:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41512422/top-3-tech-stocks-youll-regret-missing-in-q4">Top 3 Tech Stocks You&#8217;ll Regret Missing In Q4</a></li>
</ul>

Pre-Market Outlook

CSGP

DBVT

EWBC

RKLB

TSLA

Tesla To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday

Piper Sandler analyst Clarke Jeffries maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Overweight and lowers the price target from $687 to $670.

Piper Sandler Maintains Overweight on Synopsys, Lowers Price Target to $670

Investors with significant funds have taken a bullish position in Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), a development that retail traders should be aware of.
This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in SNPS usually indicates foreknowledge of upcoming events.
Today, Benzinga's options scanner identified 8 options transactions for Synopsys. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 62% being bullish and 25% bearish. Of all the options we discovered, 7 are puts, valued at $246,230, and there was a single call, worth $75,900.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $520.0 and $600.0 for Synopsys, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Synopsys's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Synopsys's whale activity within a strike price range from $520.0 to $600.0 in the last 30 days. 
<h3>Synopsys Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729605666_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$23.5</td>
<td>$23.0</td>
<td>$23.0</td>
<td>$520.00</td>
<td>$75.9K</td>
<td style="text-align: right;">93</td>
<td style="text-align: right;">33</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$106.0</td>
<td>$104.2</td>
<td>$104.2</td>
<td>$600.00</td>
<td>$41.6K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">20</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$104.1</td>
<td>$102.0</td>
<td>$102.0</td>
<td>$600.00</td>
<td>$40.8K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$104.1</td>
<td>$101.1</td>
<td>$101.1</td>
<td>$600.00</td>
<td>$40.4K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">4</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$104.1</td>
<td>$99.3</td>
<td>$99.3</td>
<td>$600.00</td>
<td>$39.7K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">8</td>
</tr>
</tbody>
</table>

<h3>About Synopsys</h3>
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Following our analysis of the options activities associated with Synopsys, we pivot to a closer look at the company's own performance.
<h3>Current Position of Synopsys</h3>
<ul>
<li>With a trading volume of 35,433, the price of SNPS is down by -1.11%, reaching $500.0.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 36 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Synopsys</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $650.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $640. 
&#x2A; An analyst from Berenberg downgraded its action to Buy with a price target of $660. 
&#x2A; In a cautious move, an analyst from Mizuho downgraded its rating to Outperform, setting a price target of $650. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Synopsys options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Market Whales and Their Recent Bets on SNPS Options

Ratings for Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $655.0, a high estimate of $687.00, and a low estimate of $635.00. This upward trend is apparent, with the current average reflecting a 1.15% increase from the previous average price target of $647.57.
<img src="https://www.benzinga.com/files/images/story/2024/1729598447_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Synopsys. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$650.00</td>
<td>-</td>
</tr>
<tr>
<td>Nay Soe Naing</td>
<td>Berenberg</td>
<td>Announces</td>
<td>Buy</td>
<td>$660.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$635.00</td>
<td>$635.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$685.00</td>
<td>$655.00</td>
</tr>
<tr>
<td>Joe Vruwink</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$663.00</td>
<td>$661.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Clarke Jeffries</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$687.00</td>
<td>$687.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$635.00</td>
<td>$615.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Synopsys. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Synopsys compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Synopsys's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Synopsys's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SNPS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Synopsys analyst ratings.</a>
<h2>All You Need to Know About Synopsys</h2>
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
<h3>Understanding the Numbers: Synopsys's Finances</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Synopsys's revenue growth over a period of 3 months has been noteworthy. As of 31 July, 2024, the company achieved a revenue growth rate of approximately 12.65%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Synopsys's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 26.74%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Synopsys's ROE stands out, surpassing industry averages. With an impressive ROE of 5.49%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Synopsys's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.6%, the company showcases efficient use of assets and strong financial health.
Debt Management: Synopsys's debt-to-equity ratio is below the industry average at 0.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings For Synopsys

Needham analyst Charles Shi reiterates Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy and maintains $640 price target.

Reiteration

Needham Reiterates Buy on Synopsys, Maintains $640 Price Target

Mizuho analyst Siti Panigrahi initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Outperform rating and announces Price Target of $650.

Mizuho Initiates Coverage On Synopsys with Outperform Rating, Announces Price Target of $650

Synopsys's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NYSE">SNPS</a>) short percent of float has risen 7.43% since its last report. The company recently reported that it has 2.88 million shares sold short, which is 1.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.83 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Synopsys Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729526431_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Synopsys has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Synopsys's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Synopsys's peer group average for short interest as a percentage of float is 3.25%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(SNPS) - Analyzing Synopsys's Short Interest

Whales with a lot of money to spend have taken a noticeably bearish stance on Synopsys.
Looking at options history for Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $423,980 and 16, calls, for a total amount of $811,190.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $420.0 and $610.0 for Synopsys, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Synopsys's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Synopsys's significant trades, within a strike price range of $420.0 to $610.0, over the past month.
<h3>Synopsys Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729284326_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$55.0</td>
<td>$50.8</td>
<td>$50.8</td>
<td>$420.00</td>
<td>$213.3K</td>
<td style="text-align: right;">80</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$63.3</td>
<td>$61.0</td>
<td>$61.0</td>
<td>$600.00</td>
<td>$91.5K</td>
<td style="text-align: right;">150</td>
<td style="text-align: right;">64</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$31.9</td>
<td>$31.4</td>
<td>$31.6</td>
<td>$510.00</td>
<td>$69.5K</td>
<td style="text-align: right;">103</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$31.9</td>
<td>$31.5</td>
<td>$31.5</td>
<td>$510.00</td>
<td>$63.0K</td>
<td style="text-align: right;">103</td>
<td style="text-align: right;">72</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$61.0</td>
<td>$60.0</td>
<td>$60.0</td>
<td>$600.00</td>
<td>$60.0K</td>
<td style="text-align: right;">150</td>
<td style="text-align: right;">116</td>
</tr>
</tbody>
</table>

<h3>About Synopsys</h3>
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Following our analysis of the options activities associated with Synopsys, we pivot to a closer look at the company's own performance.
<h3>Where Is Synopsys Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 854,725, with SNPS's price up by 0.46%, positioned at $507.03.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 40 days.</li>
</ul>
<h3>What Analysts Are Saying About Synopsys</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $660.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Berenberg downgraded its rating to Buy, setting a price target of $660. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Synopsys, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Behind the Scenes of Synopsys's Latest Options Trends

CDNS

INTZ

VERB

ZENA

Shares of software companies are trading lower. The sector may be falling amid sympathy for overall market weakness after ASML and UnitedHealth Group reported Q3 results.

During the last three months, 7 analysts shared their evaluations of Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $657.86, a high estimate of $687.00, and a low estimate of $635.00. Observing a 1.39% increase, the current average has risen from the previous average price target of $648.83. 
<img src="https://www.benzinga.com/files/images/story/2024/1729000846_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Synopsys among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nay Soe Naing</td>
<td>Berenberg</td>
<td>Announces</td>
<td>Buy</td>
<td>$660.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$635.00</td>
<td>$635.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$685.00</td>
<td>$655.00</td>
</tr>
<tr>
<td>Joe Vruwink</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$663.00</td>
<td>$661.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Clarke Jeffries</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$687.00</td>
<td>$687.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$635.00</td>
<td>$615.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Synopsys. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Synopsys compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Synopsys's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Synopsys's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SNPS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Synopsys analyst ratings.</a>
<h2>Unveiling the Story Behind Synopsys</h2>
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
<h3>Key Indicators: Synopsys's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Synopsys displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately 12.65%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Synopsys's net margin excels beyond industry benchmarks, reaching 26.74%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Synopsys's ROE stands out, surpassing industry averages. With an impressive ROE of 5.49%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Synopsys's ROA stands out, surpassing industry averages. With an impressive ROA of 3.6%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Synopsys's debt-to-equity ratio is below the industry average at 0.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Navigating 7 Analyst Ratings For Synopsys

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BTIG analyst Gregory Lewis initiated coverage on DHT Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHT#NYSE">DHT</a>) with a Buy rating and announced a price target of $16. DHT shares fell 3.2% to close at $11.34 on Monday. <a href="https://www.benzinga.com/quote/DHT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Berenberg analyst Nay Soe Naing initiated coverage on Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announced a price target of $660. Synopsys shares gained 1% to close at $545.46 on Monday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald analyst Ross Osborn initiated coverage on LeMaitre Vascular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMAT#NASDAQ">LMAT</a>) with a Neutral rating and announced a price target of $96. LeMaitre Vascular shares gained 1.7% to close at $92.14 on Monday. <a href="https://www.benzinga.com/quote/LMAT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst Michael Albanese initiated coverage on MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy rating and announced a price target of $40. MarineMax shares gained 5.3% to close at $33.13 on Monday. <a href="https://www.benzinga.com/quote/HZO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Ryan Levine initiated coverage on Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Neutral rating and announced a price target of $284. Constellation Energy shares gained 2.1% to close at $271.74 on Monday. <a href="https://www.benzinga.com/quote/CEG/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying SNPS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-1024x500.png" alt="" class="wp-image-596155" style="width:618px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116.png 1357w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More:<a href="https://www.benzinga.com/markets/24/10/41327296/jim-cramer-is-worried-about-this-plane-maker-says-palo-alto-is-a-good-one"> </a>
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41327296/jim-cramer-is-worried-about-this-plane-maker-says-palo-alto-is-a-good-one">Jim Cramer Is Worried About This Plane Maker, Says Palo Alto Is A &#8216;Good&#8217; One</a></li>
</ul>

LMAT

This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Berenberg analyst Nay Soe Naing initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announces Price Target of $660.

Berenberg Initiates Coverage On Synopsys with Buy Rating, Announces Price Target of $660

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) has outperformed the market over the past 15 years by 11.52% on an annualized basis producing an average annual return of 23.27%. Currently, Synopsys has a market capitalization of $82.18 billion. 
Buying $1000 In SNPS: If an investor had bought $1000 of SNPS stock 15 years ago, it would be worth $22,939.99 today based on a price of $534.98 for SNPS at the time of writing.
<h3>Synopsys's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728576025_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Synopsys 15 Years Ago Would Be Worth Today

Synopsys's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NYSE">SNPS</a>) short percent of float has fallen 8.85% since its last report. The company recently reported that it has 2.68 million shares sold short, which is 1.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Synopsys Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728063914_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Synopsys has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Synopsys's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Synopsys's peer group average for short interest as a percentage of float is 3.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Synopsys (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snps#NASDAQ">SNPS</a>) shares have experienced a pullback in recent times, with shares now trading 19.7% below its 52-week high of $629.38 achieved on Sept. 30.
Over the past three months, Synopsys shares have plunged 16.9%, underperforming the broader Zacks Computer &amp; Technology Sector&#39;s decline of 1.1% and the Zacks Computer &ndash; Software industry&#39;s fall of 2.7%.
Synopsys is currently facing several challenges, including a rise in cost of revenues and operating expenses. In the third quarter of fiscal 2024, these costs increased to $1.17 billion compared to $1.01 billion in the same period last year. This sharp rise has raised concerns about the company&#39;s ability to manage its rising costs effectively.
SNPS faces intense competition in the semiconductor and electronic design automation (EDA) space, which has been a headwind. Delays in realizing synergies from recent acquisitions have been a concern.
<div class="chart_embed">
<h2>Synopsys, Inc. Price and Consensus</h2>
<img alt="Synopsys, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/2b/1727786842.png" style="height:278px; width:620px" title="" />
Synopsys, Inc. price-consensus-chart | Synopsys, Inc. Quote
Does the dip in SNPS shares make the stock attractive? Let&#39;s analyze.
</div>
<h2>Synopsys Prospects Ride on Strong Portfolio</h2>
Synopsys&#39; innovative product lineup is expected to boost its prospects. The shift toward hybrid working is driving demand for higher bandwidth, which bodes well for the company&#39;s solutions. The rising demand for AI, 5G and IoT benefits SNPS&#39; prospects.
Synopsys reported strong revenues in the third quarter of fiscal 2024, with revenues increasing 13% year over year to $1.53 billion, in line with the Zacks Consensus Estimate.
SNPS anticipates achieving approximately 15% revenue growth for fiscal 2024. For fiscal 2024, it expects revenues between $6.105 billion and $6.135 billion.
The Zacks Consensus Estimate for revenues is pegged at $6.13 billion, indicating year-over-year growth of 4.93%.
For fiscal 2024, non-GAAP earnings are expected in the range of $13.07-$13.12 per share. The consensus mark for earnings is pegged at $13.12 per share, unchanged over the past 30 days.
For the fourth quarter of 2024, Synopsys expects revenues between $1.614 billion and $1.644 billion. The Zacks Consensus Estimate for fourth-quarter fiscal 2024 is currently pegged at 3.28 per share, up by a penny over the past 30 days.
Non-GAAP earnings are expected to be between $3.27 per share and $3.32 per share. The consensus mark for fourth-quarter fiscal 2024 revenues is pegged at $1.62 billion, indicating year-over-year growth of 1.01%.
<h2>Will Acquisitions Help SNPS Stock Rebound?</h2>
Synopsys has made several acquisitions to expand its product portfolio and drive growth. Over the past five years, it acquired more than 15 companies, including Intrinsic ID and Valtrix in 2024.&nbsp;
Synopsys is in the process of acquiring ANSYS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>), a move designed to strengthen its Silicon to Systems strategy, particularly in sectors such as automotive, aerospace and industrial. This acquisition is expected to expand Synopsys&#39; customer base and enhance its product offerings.
<h2>Slowing Top-Line Growth, Stiff Competition Concerns for SNPS</h2>
Synopsys&#39; Design Automation segment saw slower growth in the third quarter of fiscal 2024. Revenues from this segment increased a modest 6% year over year, reaching $1.06 billion. In comparison, the same segment saw 23% growth in the third quarter of fiscal 2023, reaching $1.0 billion.
This downturn was due to tough competition in the EDA market, where Synopsys competes with major players like Cadence Design Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdns#NASDAQ">CDNS</a>) and Mentor Graphics.&nbsp;
Unfavorable forex and a challenging macroeconomic environment are major deterrents for investors.
<h2>Zacks Rank &amp; Valuation</h2>
Synopsys currently carries a Zacks Rank #3 (Hold), suggesting that it may be wise to wait for a more favorable entry point in the stock.
Its Value Score of D indicates a stretched valuation at this moment.
In terms of forward Price/Earnings, SNPS is currently trading at 34.82X, higher than the broader sector&#39;s 32.33X.
<h2>A Top-Ranked Stock to Consider</h2>
Progress Software (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prgs#NASDAQ">PRGS</a>) is a better-ranked stock in the broader sector, sporting a Zacks Rank #1 (Strong Buy).
Long term earnings growth rate is currently pegged at 2%. Progress Software shares have appreciated 23.2% year to date.
<a href="https://www.zacks.com/stock/news/2344135/snps-drops-20-from-52-week-high-is-the-stock-worth-buying-on-dip?cid=CS-BENZ-FT-analyst_blog|rank_focused-2344135">To read this article on Zacks.com click here.</a>

Earnings

Macro Economic Events

Mid Cap

Offerings

Economics

PRGS

SNPS Drops 20% From 52-Week High: Is the Stock Worth Buying on Dip?

Cadence carries bookings momentum into fourth quarter: analysts

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Synopsys (NASDAQ:<a href="https://investorplace.com/stock-quotes/snps-stock-quote/">SNPS</a>) just reported results for the third quarter of 2024.<ul><li>Synopsys reported earnings per share of $3.43. This was above the analyst estimate for EPS of $3.28.</li><li>The company reported revenue of $1.53 billion.</li><li>This was 0.39% better than the analyst estimate for revenue of $1.52 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/snps-stock-earnings-synopsys-for-q3-of-2024/">SNPS Stock Earnings: Synopsys Beats EPS, Beats Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SNPS Stock Earnings: Synopsys Beats EPS, Beats Revenue for Q3 2024

Palantir surges after 'eye-popping quarter' as Wall Street praises AI initiatives

Aristotle Large Cap Growth Q3 2024 Commentary

KeyBanc feels strongly about software stocks under Trump presidency

Loop Capital analyst Gary Mobley initiated coverage of Synopsys (SNPS) with a Buy rating and $675 price target Published first on TheFly – the ulti...

Synopsys initiated with a Buy at Loop Capital

Loop Capital initiated coverage of Synopsys (SNPS) with a Buy rating and $675 price target The firm sees increasing captive chip designs coming fro...

Loop starts Synopsys at Buy, sees ingredients for consistent revenue growth

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Comments

Synopsys

뉴스

에 대한 최신 뉴스 Synopsys (NASDAQ:SNPS) 주식

토요일, 8월 10, 2024

수요일, 5월 22, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌